Short answer
Larimar Therapeutics, Inc. (LRMR) filed an 8-K current report with the SEC on May 14, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events). Item 2.02 contains only standard non-incorporation and liability-disclaimer language.
Larimar Therapeutics, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Item 2.02 contains only standard non-incorporation and liability-disclaimer language
- No earnings figures, reporting period details, or operating results provided in the submitted text
Item 8.01 · Other Events
- Updated investor presentation posted May 14, 2026 and furnished as Exhibit 99.2
- Presentation intended for ongoing meetings with investors, analysts and other stakeholders
- Material details depend on the presentation’s substantive disclosures, not the 8-K item itself
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Larimar Therapeutics, Inc. 8-K filings
Get the next LRMR 8-K as it lands
Follow LRMR for push alerts, or ask the research agent what this filing means.